Clinical Trials Browser

Phase 1/2 × Lung Neoplasms × motesanib diphosphate × Clear all

NCT00094835 2016-03-24

Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 1/2 Completed

51 enrolled 23 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms